Clinical trial Recruiting at 1 site Interventional Ages 18 to 64

Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk

Official title: Efficacy of Videoconference-Based Brief Cognitive-Behavioral Therapy (V-BCBT) for Patients With Mood Disorders at High Risk for Suicide: Identifying Inflammatory Biomarkers of Suicide Risk and Examining Their Mediating Role in Treatment Effects

Run by Asan Medical Center · NCT07857291 · Data updated 2026-11-12

This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment320 (estimated)
SponsorAsan Medical Center
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedNovember 4, 2026
Main results expectedAugust 2031
Study endsAugust 2031
Registry record updatedNovember 9, 2026
Trial IDNCT07857291 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-64 with a depressive or bipolar disorder in a current major depressive episode, including those at high suicide risk or low risk, and healthy controls without DSM-5 psychiatric history.

Probably not a fit

Patients with active psychosis, current substance use disorder, significant inflammatory/immune disorders, recent pregnancy, cancer, or recent psychotherapy may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study has a cross-sectional baseline comparison followed by a randomized controlled trial to examine inflammatory biomarkers related to suicide risk and to test the effectiveness of videoconference-based brief cognitive-behavioral therapy (V-BCBT) in mood disorder patients. Participants include adults with depressive disorders or bipolar and related disorders, some at high suicide risk and others at low risk, plus healthy controls. All participants will undergo clinical interviews, self-report questionnaires, a Death Implicit Association Test, and blood sampling to profile inflammatory markers. The intervention arm receives V-BCBT, while the control arm receives treatment as usual, with outcomes including mood symptoms and suicidality, as well as biomarker correlations. The study aims to identify biomarkers linked to suicide risk and to assess whether V-BCBT can reduce risk indicators and improve clinical outcomes.

Why it matters

Potential benefit: If successful, participants at high suicide risk may experience reductions in suicidal thoughts and mood symptoms, along with possible biomarker changes linked to lower risk.

How similar studies have gone: Prior work in online CBT has shown benefits for mood symptoms; this study adds biomarker assessment and a suicide-risk focus, representing a somewhat novel combination.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 64 years.
* For patient groups: diagnosis of a depressive disorder or bipolar and related disorder with a current major depressive episode according to DSM-5 criteria, as assessed using the Mini International Neuropsychiatric Interview (MINI).
* For the high-suicide-risk group: either a suicide attempt within the past month or a Beck Scale for Suicide Ideation (SSI) score of ≥15.
* For healthy controls: no lifetime history of any DSM-5 psychiatric disorder, as assessed using the MINI.

Exclusion Criteria:

* Presence of psychotic symptoms or a current substance use disorder.
* Diagnosis of an inflammatory or autoimmune disease.
* Use of corticosteroids or immunosuppressive medications within the past month.
* Current pregnancy or breastfeeding.
* Diagnosis of cancer within the past 5 years.
* Physical injury or infectious illness within the past month.
* Night-shift work within the past 2 months.
* Receipt of psychotherapy or psychological treatment within the past 3 months.
* Use of anti-inflammatory medications within the past 2 weeks.

Where it's running

  • Asan Medical Center
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.